메뉴 건너뛰기




Volumn 8, Issue 9, 2013, Pages

Convergent RANK- and c-Met-Mediated Signaling Components Predict Survival of Patients with Prostate Cancer: An Interracial Comparative Study

Author keywords

[No Author keywords available]

Indexed keywords

NEUROPILIN 1; OSTEOCLAST DIFFERENTIATION FACTOR; QUANTUM DOT; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; SCATTER FACTOR RECEPTOR; TRANSCRIPTION FACTOR RELA; VASCULOTROPIN;

EID: 84884198298     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0073081     Document Type: Article
Times cited : (14)

References (28)
  • 1
    • 84870778852 scopus 로고    scopus 로고
    • Predicting response to hormonal therapy and survival in men with hormone sensitive metastatic prostate cancer
    • Grivas PD, Robins DM, Hussain M, (2013) Predicting response to hormonal therapy and survival in men with hormone sensitive metastatic prostate cancer. Crit Rev Oncol Hematol 85: 82-93.
    • (2013) Crit Rev Oncol Hematol , vol.85 , pp. 82-93
    • Grivas, P.D.1    Robins, D.M.2    Hussain, M.3
  • 2
    • 84872280376 scopus 로고    scopus 로고
    • The role of treatment modality on the utility of predictive tissue biomarkers in clinical prostate cancer: a systematic review
    • Kachroo N, Gnanapragasam VJ, (2013) The role of treatment modality on the utility of predictive tissue biomarkers in clinical prostate cancer: a systematic review. J Cancer Res Clin Oncol 139: 1-24.
    • (2013) J Cancer Res Clin Oncol , vol.139 , pp. 1-24
    • Kachroo, N.1    Gnanapragasam, V.J.2
  • 3
    • 84862525933 scopus 로고    scopus 로고
    • Tissue biomarkers for prostate cancer radiation therapy
    • Tran PT, Hales RK, Zeng J, Aziz K, Salih T, et al. (2012) Tissue biomarkers for prostate cancer radiation therapy. Curr Mol Med 12: 772-787.
    • (2012) Curr Mol Med , vol.12 , pp. 772-787
    • Tran, P.T.1    Hales, R.K.2    Zeng, J.3    Aziz, K.4    Salih, T.5
  • 4
    • 0033153362 scopus 로고    scopus 로고
    • Osteomimetic properties of prostate cancer cells: a hypothesis supporting the predilection of prostate cancer metastasis and growth in the bone environment
    • Koeneman KS, Yeung F, Chung LW, (1999) Osteomimetic properties of prostate cancer cells: a hypothesis supporting the predilection of prostate cancer metastasis and growth in the bone environment. Prostate 39: 246-261.
    • (1999) Prostate , vol.39 , pp. 246-261
    • Koeneman, K.S.1    Yeung, F.2    Chung, L.W.3
  • 6
    • 83755185942 scopus 로고    scopus 로고
    • Multiplexed quantum dot labeling of activated c-Met signaling in castration-resistant human prostate cancer
    • Hu P, Chu GC, Zhu G, Yang H, Luthringer D, et al. (2011) Multiplexed quantum dot labeling of activated c-Met signaling in castration-resistant human prostate cancer. PLoS One 6: e28670.
    • (2011) PLoS One , vol.6
    • Hu, P.1    Chu, G.C.2    Zhu, G.3    Yang, H.4    Luthringer, D.5
  • 7
    • 81155137295 scopus 로고    scopus 로고
    • LIV-1 promotes prostate cancer epithelial-to-mesenchymal transition and metastasis through HB-EGF shedding and EGFR-mediated ERK signaling
    • Lue HW, Yang X, Wang R, Qian W, Xu RZ, et al. (2011) LIV-1 promotes prostate cancer epithelial-to-mesenchymal transition and metastasis through HB-EGF shedding and EGFR-mediated ERK signaling. PLoS One 6: e27720.
    • (2011) PLoS One , vol.6
    • Lue, H.W.1    Yang, X.2    Wang, R.3    Qian, W.4    Xu, R.Z.5
  • 8
    • 49149114127 scopus 로고    scopus 로고
    • Receptor activator of NF-kappaB Ligand (RANKL) expression is associated with epithelial to mesenchymal transition in human prostate cancer cells
    • Odero-Marah VA, Wang R, Chu G, Zayzafoon M, Xu J, et al. (2008) Receptor activator of NF-kappaB Ligand (RANKL) expression is associated with epithelial to mesenchymal transition in human prostate cancer cells. Cell Res 18: 858-870.
    • (2008) Cell Res , vol.18 , pp. 858-870
    • Odero-Marah, V.A.1    Wang, R.2    Chu, G.3    Zayzafoon, M.4    Xu, J.5
  • 9
    • 33750466563 scopus 로고    scopus 로고
    • Prostate cancer metastasis: role of the host microenvironment in promoting epithelial to mesenchymal transition and increased bone and adrenal gland metastasis
    • Xu J, Wang R, Xie ZH, Odero-Marah V, Pathak S, et al. (2006) Prostate cancer metastasis: role of the host microenvironment in promoting epithelial to mesenchymal transition and increased bone and adrenal gland metastasis. Prostate 66: 1664-1673.
    • (2006) Prostate , vol.66 , pp. 1664-1673
    • Xu, J.1    Wang, R.2    Xie, Z.H.3    Odero-Marah, V.4    Pathak, S.5
  • 10
    • 84872715614 scopus 로고    scopus 로고
    • Epidermal growth factor promotes protein degradation of epithelial protein lost in neoplasm (EPLIN), a putative metastasis suppressor, during epithelial-mesenchymal transition
    • Zhang S, Wang X, Iqbal S, Wang Y, Osunkoya AO, et al. (2013) Epidermal growth factor promotes protein degradation of epithelial protein lost in neoplasm (EPLIN), a putative metastasis suppressor, during epithelial-mesenchymal transition. J Biol Chem 288: 1469-1479.
    • (2013) J Biol Chem , vol.288 , pp. 1469-1479
    • Zhang, S.1    Wang, X.2    Iqbal, S.3    Wang, Y.4    Osunkoya, A.O.5
  • 11
    • 83555173589 scopus 로고    scopus 로고
    • EPLIN downregulation promotes epithelial-mesenchymal transition in prostate cancer cells and correlates with clinical lymph node metastasis
    • Zhang S, Wang X, Osunkoya AO, Iqbal S, Wang Y, et al. (2011) EPLIN downregulation promotes epithelial-mesenchymal transition in prostate cancer cells and correlates with clinical lymph node metastasis. Oncogene 30: 4941-4952.
    • (2011) Oncogene , vol.30 , pp. 4941-4952
    • Zhang, S.1    Wang, X.2    Osunkoya, A.O.3    Iqbal, S.4    Wang, Y.5
  • 12
    • 47549095025 scopus 로고    scopus 로고
    • Epithelial to mesenchymal transition (EMT) in human prostate cancer: lessons learned from ARCaP model
    • Zhau HE, Odero-Marah V, Lue HW, Nomura T, Wang R, et al. (2008) Epithelial to mesenchymal transition (EMT) in human prostate cancer: lessons learned from ARCaP model. Clin Exp Metastasis 25: 601-610.
    • (2008) Clin Exp Metastasis , vol.25 , pp. 601-610
    • Zhau, H.E.1    Odero-Marah, V.2    Lue, H.W.3    Nomura, T.4    Wang, R.5
  • 13
    • 84860827142 scopus 로고    scopus 로고
    • Denosumab in castration-resistant prostate cancer
    • author reply e50-51
    • Kyrgidis A, Tzellos TG (2012) Denosumab in castration-resistant prostate cancer. Lancet 379: e50; author reply e50-51.
    • (2012) Lancet , vol.379
    • Kyrgidis, A.1    Tzellos, T.G.2
  • 14
    • 84875079780 scopus 로고    scopus 로고
    • Progesterone drives mammary secretory differentiation via RankL-mediated induction of Elf5 in luminal progenitor cells
    • Lee HJ, Gallego-Ortega D, Ledger A, Schramek D, Joshi P, et al. (2013) Progesterone drives mammary secretory differentiation via RankL-mediated induction of Elf5 in luminal progenitor cells. Development 140: 1397-1401.
    • (2013) Development , vol.140 , pp. 1397-1401
    • Lee, H.J.1    Gallego-Ortega, D.2    Ledger, A.3    Schramek, D.4    Joshi, P.5
  • 15
    • 78149284013 scopus 로고    scopus 로고
    • Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer
    • Schramek D, Leibbrandt A, Sigl V, Kenner L, Pospisilik JA, et al. (2010) Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer. Nature 468: 98-102.
    • (2010) Nature , vol.468 , pp. 98-102
    • Schramek, D.1    Leibbrandt, A.2    Sigl, V.3    Kenner, L.4    Pospisilik, J.A.5
  • 16
    • 84905118561 scopus 로고    scopus 로고
    • Autocrine/paracrine RANKL-RANK signaling promotes cancer bone metastasis and establishes premetastatic niche recruiting bystander cancer cells to participate in the metastatic process
    • Walter E. Washington Convention Center, Washington, DC. #3942
    • Chu GCY, Zhau HE, Wang R, Rogatko A, Feng X, et al. (2013) Autocrine/paracrine RANKL-RANK signaling promotes cancer bone metastasis and establishes premetastatic niche recruiting bystander cancer cells to participate in the metastatic process. American Association for Cancer Research, 2013 Annual Meeting. Walter E. Washington Convention Center, Washington, DC. #3942.
    • (2013) American Association for Cancer Research, 2013 Annual Meeting
    • Chu, G.C.Y.1    Zhau, H.E.2    Wang, R.3    Rogatko, A.4    Feng, X.5
  • 17
    • 0036985699 scopus 로고    scopus 로고
    • Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications
    • Ferrara N, (2002) Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications. Semin Oncol 29: 10-14.
    • (2002) Semin Oncol , vol.29 , pp. 10-14
    • Ferrara, N.1
  • 18
    • 0031938669 scopus 로고    scopus 로고
    • Angiogenesis and prostate cancer: in vivo and in vitro expression of angiogenesis factors by prostate cancer cells
    • Ferrer FA, Miller LJ, Andrawis RI, Kurtzman SH, Albertsen PC, et al. 1998) Angiogenesis and prostate cancer: in vivo and in vitro expression of angiogenesis factors by prostate cancer cells. Urology 51: 161-167.
    • (1998) Urology , vol.51 , pp. 161-167
    • Ferrer, F.A.1    Miller, L.J.2    Andrawis, R.I.3    Kurtzman, S.H.4    Albertsen, P.C.5
  • 19
    • 0029761644 scopus 로고    scopus 로고
    • Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
    • Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, et al. (1996) Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16: 4604-4613.
    • (1996) Mol Cell Biol , vol.16 , pp. 4604-4613
    • Forsythe, J.A.1    Jiang, B.H.2    Iyer, N.V.3    Agani, F.4    Leung, S.W.5
  • 20
    • 0032549799 scopus 로고    scopus 로고
    • Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor
    • Soker S, Takashima S, Miao HQ, Neufeld G, Klagsbrun M, (1998) Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92: 735-745.
    • (1998) Cell , vol.92 , pp. 735-745
    • Soker, S.1    Takashima, S.2    Miao, H.Q.3    Neufeld, G.4    Klagsbrun, M.5
  • 21
    • 0035816698 scopus 로고    scopus 로고
    • Vascular endothelial growth factor receptor-2 and neuropilin-1 form a receptor complex that is responsible for the differential signaling potency of VEGF (165) and VEGF (121)
    • Whitaker GB, Limberg BJ, Rosenbaum JS, (2001) Vascular endothelial growth factor receptor-2 and neuropilin-1 form a receptor complex that is responsible for the differential signaling potency of VEGF (165) and VEGF (121). J Biol Chem 276: 25520-25531.
    • (2001) J Biol Chem , vol.276 , pp. 25520-25531
    • Whitaker, G.B.1    Limberg, B.J.2    Rosenbaum, J.S.3
  • 22
    • 84878167182 scopus 로고    scopus 로고
    • VEGFR1 and NRP1 endothelial expressions predict distant relapse after radical prostatectomy in clinically localized prostate cancer
    • Talagas M, Uguen A, Garlantezec R, Fournier G, Doucet L, et al. (2013) VEGFR1 and NRP1 endothelial expressions predict distant relapse after radical prostatectomy in clinically localized prostate cancer. Anticancer Res 33: 2065-2075.
    • (2013) Anticancer Res , vol.33 , pp. 2065-2075
    • Talagas, M.1    Uguen, A.2    Garlantezec, R.3    Fournier, G.4    Doucet, L.5
  • 23
    • 76749152925 scopus 로고    scopus 로고
    • Vascular endothelial growth factor regulates myeloid cell leukemia-1 expression through neuropilin-1-dependent activation of c-MET signaling in human prostate cancer cells
    • Zhang S, Zhau HE, Osunkoya AO, Iqbal S, Yang X, et al. (2010) Vascular endothelial growth factor regulates myeloid cell leukemia-1 expression through neuropilin-1-dependent activation of c-MET signaling in human prostate cancer cells. Mol Cancer 9: 9.
    • (2010) Mol Cancer , vol.9 , pp. 9
    • Zhang, S.1    Zhau, H.E.2    Osunkoya, A.O.3    Iqbal, S.4    Yang, X.5
  • 24
    • 77953441434 scopus 로고    scopus 로고
    • Molecular mechanisms involving prostate cancer racial disparity
    • Hatcher D, Daniels G, Osman I, Lee P, (2009) Molecular mechanisms involving prostate cancer racial disparity. Am J Transl Res 1: 235-248.
    • (2009) Am J Transl Res , vol.1 , pp. 235-248
    • Hatcher, D.1    Daniels, G.2    Osman, I.3    Lee, P.4
  • 25
    • 7444267851 scopus 로고    scopus 로고
    • Racial disparity in clinical course and outcome of metastatic androgen-independent prostate cancer
    • Thatai LC, Banerjee M, Lai Z, Vaishampayan U, (2004) Racial disparity in clinical course and outcome of metastatic androgen-independent prostate cancer. Urology 64: 738-743.
    • (2004) Urology , vol.64 , pp. 738-743
    • Thatai, L.C.1    Banerjee, M.2    Lai, Z.3    Vaishampayan, U.4
  • 26
    • 34447128753 scopus 로고    scopus 로고
    • Age-related DNA methylation changes in normal human prostate tissues
    • Kwabi-Addo B, Chung W, Shen L, Ittmann M, Wheeler T, et al. (2007) Age-related DNA methylation changes in normal human prostate tissues. Clin Cancer Res 13: 3796-3802.
    • (2007) Clin Cancer Res , vol.13 , pp. 3796-3802
    • Kwabi-Addo, B.1    Chung, W.2    Shen, L.3    Ittmann, M.4    Wheeler, T.5
  • 27
    • 0031398541 scopus 로고    scopus 로고
    • Interracial comparative study of prostate cancer in the United States, China, and Japan
    • Zhau HE, Zhao LS, Chen BQ, Kojima M (1997) Interracial comparative study of prostate cancer in the United States, China, and Japan. J Cell Biochem Suppl 28-29: 182-185.
    • (1997) J Cell Biochem Suppl , vol.28-29 , pp. 182-185
    • Zhau, H.E.1    Zhao, L.S.2    Chen, B.Q.3    Kojima, M.4
  • 28
    • 0003935701 scopus 로고
    • Comparative studies of prostate cancers among United States, Chinese, and Japanese patients: characterization of histopathology, tumor angiogenesis, neuroendocrine factors, and p53 protein accumulations
    • Zhau HE, Zhao LS, Chung LW, Chen BQ, Troncoso P, et al. (1995) Comparative studies of prostate cancers among United States, Chinese, and Japanese patients: characterization of histopathology, tumor angiogenesis, neuroendocrine factors, and p53 protein accumulations. Urol Oncol 1: 51-63.
    • (1995) Urol Oncol , vol.1 , pp. 51-63
    • Zhau, H.E.1    Zhao, L.S.2    Chung, L.W.3    Chen, B.Q.4    Troncoso, P.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.